Richardson Electronics RELL Gain Loss On Disposal Of Healthcare Assets And Other Charges

Gain Loss On Disposal Of Healthcare Assets And Other Charges at other companies

AAR CorpAIR

-$400K+99.4%

Goodyear Tire & Rubber CompanyGT

$3M-98.9%

Conduent IncorporatedCNDT

-$500K-100%

Leggett & PlattLEG

$9.4M+348%

Surgery Partners, Inc.SGRY

-$4.3M+32.8%

John Wiley & Sons, Inc.WLYB

-$1.24M+90.9%

Other financials

Income statement

See full

Revenue$55.5M+3.1%

Gross profit$17.7M+6.0%

Operating income$1.5M+155%

Net income$893.0K+143%

Balance sheet

See full

Cash & equivalents$29.5M-19.6%

Total debt$1.6M-22.7%

Total equity$160.2M+4.7%

Total assets$199.8M+5.3%

Cash flow

See full

Operating cash flow-$2.7M-158%

CapEx$759.0K+38.3%

Free cash flow-$3.4M-184%

Valuation

See full

Market cap$276.73M+73.0%

Enterprise value$248.81M+101%

P/E73.7×—

P/S1.3×+0.5×

Profitability

See full

Gross margin31.3%+0.4pp

Operating margin0.9%-9.9pp

Net margin1.8%+1.3pp

FCF margin-2.2%-9.4pp

Returns & leverage

See full

Return on equity2.4%+1.7pp

Debt / equity0×0.0×

Current ratio4.5×-0.2×

Where this comes from

Reported directly by Richardson Electronics in its filing.

Tagged under the XBRL concept rell:GainLossOnDisposalOfHealthcareAssetsAndOtherCharges.

The official record: Richardson Electronics’s 10-K, filed August 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about Richardson Electronics's gain loss on disposal of healthcare assets and other charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Richardson Electronics's gain loss on disposal of healthcare assets and other charges?: Richardson Electronics (RELL) reported gain loss on disposal of healthcare assets and other charges of $1.28M in Q1 2025.
What does gain loss on disposal of healthcare assets and other charges mean?: This metric captures the net financial impact resulting from the divestiture, sale, or write-down of assets specifically tied to the healthcare business unit. It provides insight into the company's strategic restructuring efforts and the realization of value from non-core or underperforming healthcare-related investments. Investors monitor this to understand the impact of portfolio optimization on the bottom line.